Please log in to save bookmarks. Only registered users can save their favorite pages.
Journal Properties
Language
English
Number of Articles
44
Abbreviation
CBF
e-ISSN
2230-2492
Main Publisher
Dove Medical Press
Publisher
Informa UK Limited
Indian UGC
DOAJ (latest)
Description
This journal provides a platform for the dissemination of research focused on the discovery, validation, and application of biomarkers across a spectrum of diseases. Its primary goal is to advance the understanding of disease mechanisms through the identification and characterization of relevant biomarkers. The scope encompasses genomic, proteomic, and metabolomic approaches. It aims to improve diagnostics, prognostics, and personalized treatment strategies. The journal covers a range of topics including biomarkers in cancer, cardiovascular diseases, neurological disorders, and infectious diseases.
It serves as a key resource for researchers, clinicians, and industry professionals involved in biomarker research. It highlights biomarker utility in early detection, risk stratification, and monitoring of therapeutic responses. Indexed in leading scientific databases, the journal ensures broad visibility and accessibility of its published content.
It is committed to open access, providing free access to high-quality research. Authors are invited to contribute original research articles, reviews, and perspectives that advance the field. By fostering collaboration and open communication, this publication aims to accelerate the translation of biomarker discoveries into tangible clinical benefits. The submission process is straightforward and promotes rapid dissemination of findings.